| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
91,977
|
103,610
|
93,818
|
96,336
| | Cost of Revenue | 33,385 | 34,220 | 34,697 | 35,381 | | |
Gross Profit
|
58,592
|
69,390
|
59,121
|
60,955
| |
|
Operating Expenses |
|
Research Development | 5,088 | 5,013 | 5,501 | 6,160 |
|
Selling General and Administrative | 28,308 | 29,943 | 30,435 | 29,279 |
|
Non Recurring | 2,662 | 14,384 | 209,545 | 2,707 |
|
Others | 15,004 | 15,897 | 14,542 | 13,632 |
|
|
|
Total Operating Expenses | 51,062 | 65,237 | 260,023 | 51,778 | | | |
Operating Income or Loss
|
7,530
|
4,153
|
(200,902)
|
9,177
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 174 | (2,100) | (346) | (364) |
|
Earnings Before Interest And Taxes | 7,704 | 2,053 | (201,248) | 8,813 |
|
Interest Expense | 8,961 | 7,563 | 7,835 | 7,838 |
|
Income Before Tax | (1,257) | (5,510) | (209,083) | 975 |
|
Income Tax Expense | (129) | 15,315 | 10,644 | 457 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (1,128) | (20,825) | (219,727) | 518 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
| (789) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(1,128)
|
(20,825)
|
(219,727)
|
(271)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(1,128)
|
(20,825)
|
(219,727)
|
(271)
|
|